Galera Therapeutics, Inc. (GRTX)
OTCMKTS · Delayed Price · Currency is USD
0.0240
0.00 (0.00%)
Nov 12, 2025, 4:00 PM EST
Galera Therapeutics Employees
Galera Therapeutics had 3 employees as of December 31, 2024. The number of employees decreased by 4 or -57.14% compared to the previous year.
Employees
3
Change (1Y)
-4
Growth (1Y)
-57.14%
Revenue / Employee
n/a
Profits / Employee
-$2,995,333
Market Cap
1.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3 | -4 | -57.14% |
| Dec 31, 2023 | 7 | -24 | -77.42% |
| Dec 31, 2022 | 31 | 1 | 3.33% |
| Dec 31, 2021 | 30 | -8 | -21.05% |
| Dec 31, 2020 | 38 | 6 | 18.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
Galera Therapeutics News
- 23 days ago - Galera Therapeutics (GRTX) Sells Asset Portfolio to Biossil - GuruFocus
- 23 days ago - Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million - GlobeNewsWire
- 11 months ago - Galera Therapeutics completes acquisition of Nova Pharmaceuticals - GlobeNewsWire
- 1 year ago - Galera Announces Board Approval of Complete Liquidation and Dissolution - GlobeNewsWire
- 1 year ago - Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 1 year ago - Galera Adopts Limited Duration Stockholder Rights Agreement - GlobeNewsWire
- 1 year ago - Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 2 years ago - Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates - GlobeNewsWire